Clinical implications of these insights into the role of adipocyte MR in obesity include whether MR blockade would be of benefit in treating obesity-associated morbidities such as hypertension, diabetes, and the metabolic syndrome. This evidence concerns the gene NR3C2 and obesity due to melanocortin 4 receptor deficiency.